ArticlePharmaceutics2025
Stability and Dissolution Behavior Changes After Drug Compounding for Pediatric Cardiovascular Pharmacotherapy.
Jumpei Saito, Akimasa Yamatani, Yuna Kojima, Masayoshi Nakakuni, Kosuke Nakano, Kaoru Hirose, Hidefumi Nakamura, Takehisa Hanawa, Miki Akabane
Abstract read
In one paragraphArticle in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Jumpei SaitoDepartment of Pharmacy, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.ORCID 0000-0003-4799-5562 Akimasa YamataniPediatric and Perinatal Medicine, Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose-shi, Tokyo 204-0004, Japan.ORCID 0000-0003-2960-5161 Yuna KojimaDepartment of Medical Design and Clinical Pharmaceutical Design, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan.
Masayoshi NakakuniDepartment of Multicenter Collaboration, Network Promotion Unit, Clinical Research Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.
Kosuke NakanoDepartment of Multicenter Collaboration, Network Promotion Unit, Clinical Research Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.
Kaoru HiroseDepartment of Medical Design and Clinical Pharmaceutical Design, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan.ORCID 0000-0003-4437-1885 Hidefumi NakamuraDepartment of Research and Development Supervision, Clinical Research Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.
Takehisa HanawaDepartment of Medical Design and Clinical Pharmaceutical Design, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan.ORCID 0000-0002-3922-025X Miki AkabaneDepartment of Pharmacy, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.
Funding
Japan Agency for Medical Research and Development 23mk0101243H0002
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
cardiovascular drugsdissolution behavioringredients stabilitypediatric compounding
Identifiers
PMID40284528
PMCPMC12030496
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390